The Latest Breaking News from FDA

The culture war comes for non-dairy milk

The FDA just announced guidance that recommends plant-based alternatives can be labeled as "milk" — for now

Salon · Mar 1, 2023

Noah Feldman: New pro-choice abortion pill lawsuit is a gamble

As a Texas federal judge mulls whether to halt the Food and Drug Administration’s longstanding approval of an abortion pill, 12 liberal states have filed a separate lawsuit in a federal district court in Washington state that seeks to force the FDA to drop some restrictions on the drug.

Tribune News Service · Mar 1, 2023

Pfizer’s RSV vaccine just won an FDA panel’s backing for safety in older people. It's a market that will be worth up to $10 billion in a decade

Pfizer is also facing off with collaborators Sanofi and AstraZeneca Plc to develop prevention for dangerous RSV infections in newborns, a market that could reach $1.5 billion.

Fortune · Feb 28, 2023

How officials cracked case of eyedrops that blinded people: 'A public health victory'

An infection that's usually easy to treat with common antibiotic eyedrops "has become an infection that can be deadly and has pretty much no treatment except one IV antibiotic,” one expert said.

Fortune · Feb 28, 2023

How officials cracked case of eyedrops that blinded people

Experts are marveling at how U.S. disease detectives figured out how eyedrops were linked to dozens of infections

The Independent UK · Feb 28, 2023

FDA authorizes first at-home combination test for COVID and flu

The Lucira COVID-19 and Flu Home Test is a single-use test, which can be purchased without a prescription.

Chicago Sun-Times · Feb 27, 2023

Prospect union members vote to strike on UK budget day

Action on 15 March likely to coincide with PCS strike, taking number of civil servants participating above 100,000

The Guardian - UK · Feb 27, 2023

1 High-Value Stock to Keep in Your Portfolio Forever

Pfizer (PFE) reported record-breaking revenue and earnings for fiscal 2022. Furthermore, the combination of expected launches and additional pipeline products position the company for continued robust growth through the rest of this decade and beyond. Amid a volatile macro environment, investing in this high-value stock for the long term could…

StockNews.com · Feb 27, 2023

Is there a vaccine for RSV or respiratory syncytial virus? After almost 60 years, several come at once

You might not have heard of respiratory syncytial virus, or RSV. But it caused more than 100,000 global deaths in 2019, making it a leading cause of death in children under one year old.

The Conversation · Feb 26, 2023

Dominic Raab says he will resign if found guilty of bullying

‘Innocent until proven guilty’, says deputy PM on investigation into allegations

The Independent UK · Feb 26, 2023